{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T09:37:19Z","timestamp":1779183439172,"version":"3.51.4"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.gene.2023.147428","type":"journal-article","created":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T14:55:24Z","timestamp":1681570524000},"page":"147428","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Identification of single nucleotide variants in SLC26A9 gene in patients with cystic fibrosis (p.Phe508del homozygous) and its association to Orkambi\u00ae (Lumacaftor and Ivacaftor) response in vitro"],"prefix":"10.1016","volume":"871","author":[{"given":"Luana Gavioli","family":"Santos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phanie Villa-Nova","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur Henrique Pezzo","family":"Kmit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciana Cardoso","family":"Bonadia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen S\u00edlvia","family":"Bertuzzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Dirceu","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ta\u00eds Nitsch","family":"Mazzola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando Augusto Lima","family":"Marson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gene.2023.147428_b0005","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","article-title":"A method and server for predicting damaging missense mutations","volume":"7","author":"Adzhubei","year":"2010","journal-title":"Nat. Methods"},{"key":"10.1016\/j.gene.2023.147428_b0010","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/j.ajhg.2022.09.004","article-title":"Pleiotropic modifiers of age-related diabetes and neonatal intestinal obstruction in cystic fibrosis","volume":"109","author":"Aksit","year":"2022","journal-title":"Am. J. Hum. Gene"},{"key":"10.1016\/j.gene.2023.147428_b0015","article-title":"Development of novel therapeutics for all individuals with CF (the future goes on)","author":"Amaral","year":"2022","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.gene.2023.147428_b0020","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1172\/JCI60429","article-title":"SLC26A9-mediated chloride secretion prevents mucus obstruction in airway inflammation","volume":"122","author":"Anagnostopoulou","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.gene.2023.147428_b0025","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/humu.22382","article-title":"Characterization of SLC26A9 in patients with CF-like lung disease","volume":"34","author":"Bakouh","year":"2013","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.gene.2023.147428_b0030","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.3389\/fphar.2018.01112","article-title":"Role of the SLC26A9 chloride channel as disease modifier and potential therapeutic target in cystic fibrosis","volume":"9","author":"Bal\u00e1zs","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.gene.2023.147428_b0035","doi-asserted-by":"crossref","first-page":"eS8 -eS12","DOI":"10.1016\/S0929-693X(20)30044-0","article-title":"CFTR gene variants, epidemiology and molecular pathology","volume":"27","author":"Bareil","year":"2020","journal-title":"Arch. Pediatr."},{"key":"10.1016\/j.gene.2023.147428_b0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1003440","article-title":"PredictSNP: robust and accurate consensus classifier for prediction of disease-related mutations","volume":"10","author":"Bendl","year":"2014","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.gene.2023.147428_b0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004962","article-title":"PredictSNP2: a unified platform for accurately evaluating SNP effects by exploiting the different characteristics of variants in distinct genomic regions","volume":"12","author":"Bendl","year":"2016","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.gene.2023.147428_b0050","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1085\/jgp.200810097","article-title":"SLC26A9 is a constitutively active, CFTR-regulated anion conductance in human bronchial epithelia","volume":"133","author":"Bertrand","year":"2009","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.gene.2023.147428_b0055","doi-asserted-by":"crossref","first-page":"5821","DOI":"10.3390\/jcm10245821","article-title":"Genetic modifying factors of cystic fibrosis phenotype: a challenge for modern medicine","volume":"10","author":"Butnariu","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.gene.2023.147428_b0060","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.3390\/cells10123500","article-title":"Alterations in SLC4A2, SLC26A7 and SLC26A9 Drive acid-base imbalance in gastric neuroendocrine tumors and uncover a novel mechanism for a co-occurring polyautoimmune scenario","volume":"10","author":"Calvete","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.gene.2023.147428_b0065","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1093\/bioinformatics\/btv195","article-title":"PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels","volume":"31","author":"Choi","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.gene.2023.147428_b0070","doi-asserted-by":"crossref","first-page":"828","DOI":"10.3389\/fphar.2018.00828","article-title":"SLC26A9 gene is associated with lung function response to ivacaftor in patients with cystic fibrosis","volume":"9","author":"Corvol","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.gene.2023.147428_b0075","doi-asserted-by":"crossref","first-page":"D988","DOI":"10.1093\/nar\/gkab1049","article-title":"Ensembl 2022","volume":"50","author":"Cunningham","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.gene.2023.147428_b0080","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3390\/diagnostics13040763","article-title":"Cystic fibrosis: a descriptive analysis of deaths in a two-decade period in brazil according to age, race, and sex","volume":"13","author":"de Azevedo","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.gene.2023.147428_b0085","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1093\/nar\/gkp215","article-title":"Human Splicing Finder: an online bioinformatics tool to predict splicing signals","volume":"37","author":"Desmet","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.gene.2023.147428_b0090","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jcf.2021.02.007","article-title":"SLC26A9 SNP rs7512462 is not associated with lung disease severity or lung function response to ivacaftor in cystic fibrosis patients with G551D-CFTR","volume":"20","author":"Eastman","year":"2021","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.gene.2023.147428_b0095","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1377\/hlthaff.2017.1554","article-title":"Precision medicine in action: the impact of Ivacaftor on cystic fibrosis-related hospitalizations","volume":"37","author":"Feng","year":"2018","journal-title":"Health Aff. (Millwood)"},{"key":"10.1016\/j.gene.2023.147428_b0100","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.chest.2018.04.036","article-title":"Ion channel modulators in cystic fibrosis","volume":"154","author":"Gentzsch","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.gene.2023.147428_b0105","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41525-022-00299-9","article-title":"Genetic evidence supports the development of SLC26A9 targeting therapies for the treatment of lung disease","volume":"7","author":"Gong","year":"2022","journal-title":"NPJ Genom. Med."},{"key":"10.1016\/j.gene.2023.147428_b0110","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3390\/biom12020202","article-title":"SLC26A9 as a potential modifier and therapeutic target in cystic fibrosis lung disease","volume":"12","author":"Gorrieri","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.gene.2023.147428_b0115","first-page":"91","article-title":"Precision medicine based on CFTR genotype for people with cystic fibrosis","volume":"15","author":"Haq","year":"2022","journal-title":"Pharmgenomics Pers. Med."},{"key":"10.1016\/j.gene.2023.147428_b0120","doi-asserted-by":"crossref","first-page":"e22534","DOI":"10.1096\/fj.202200313RR","article-title":"The SLC26A9 inhibitor S9\u2013A13 provides no evidence for a role of SLC26A9 in airway chloride secretion but suggests a contribution to regulation of ASL pH and gastric proton secretion","volume":"36","author":"Jo","year":"2022","journal-title":"FASEB J."},{"key":"10.1016\/j.gene.2023.147428_b0125","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.bbadis.2019.01.029","article-title":"Extent of rescue of F508del-CFTR function by VX-809 and VX-770 in human nasal epithelial cells correlates with SNP rs7512462 in SLC26A9 gene in F508del\/F508del Cystic Fibrosis patients","volume":"1865","author":"Kmit","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.gene.2023.147428_b0130","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1172\/JCI129833","article-title":"Increased expression of anion transporter SLC26A9 delays diabetes onset in cystic fibrosis","volume":"130","author":"Lam","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.gene.2023.147428_b0135","doi-asserted-by":"crossref","first-page":"D835","DOI":"10.1093\/nar\/gkz972","article-title":"ClinVar: improvements to accessing data","volume":"48","author":"Landrum","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.gene.2023.147428_b0140","doi-asserted-by":"crossref","first-page":"L1147","DOI":"10.1152\/ajplung.00563.2020","article-title":"Separating the contributions of SLC26A9 and CFTR to anion secretion in primary human bronchial epithelia","volume":"321","author":"Larsen","year":"2021","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.gene.2023.147428_b0145","doi-asserted-by":"crossref","DOI":"10.1111\/apha.13729","article-title":"Hydrokinetic pancreatic function and insulin secretion are moduled by Cl- uniporter SLC26A9 in mice","volume":"234","author":"Li","year":"2022","journal-title":"Acta Physiol. (Oxf.)"},{"key":"10.1016\/j.gene.2023.147428_b0150","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s00424-014-1543-x","article-title":"Loss of SLC26A9 anion transporter alters intestinal electrolyte and HCO3(-) transport and reduces survival in CFTR-deficient mice","volume":"467","author":"Liu","year":"2015","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.gene.2023.147428_b0155","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.3389\/fphar.2019.01662","article-title":"CFTR Modulators: the changing face of cystic fibrosis in the era of precision medicine","volume":"10","author":"Lopes-Pacheco","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.gene.2023.147428_b0160","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3389\/fphar.2017.00390","article-title":"Personalized or precision medicine? The example of cystic fibrosis","volume":"8","author":"Marson","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.gene.2023.147428_b0165","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/npp.2010.193","article-title":"Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia","volume":"36","author":"McClay","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.gene.2023.147428_b0170","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3390\/jpm12020252","article-title":"Factors predisposing the response to Lumacaftor\/Ivacaftor in people with cystic fibrosis","volume":"12","author":"M\u00e9sin\u00e8le","year":"2022","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.gene.2023.147428_b0175","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.jpeds.2015.01.044","article-title":"Variants in solute carrier SLC26A9 modify prenatal exocrine pancreatic damage in cystic fibrosis","volume":"166","author":"Miller","year":"2015","journal-title":"J. Pediatr."},{"key":"10.1016\/j.gene.2023.147428_b0180","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1101\/gr.176601","article-title":"Predicting deleterious amino acid substitutions","volume":"11","author":"Ng","year":"2001","journal-title":"Genome Res."},{"key":"10.1016\/j.gene.2023.147428_b0185","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1113\/JP282586","article-title":"Nasal epithelial cells as a gold-standard predictive model for personalized medicine in cystic fibrosis","volume":"600","author":"Pedemonte","year":"2022","journal-title":"J. Physiol."},{"key":"10.1016\/j.gene.2023.147428_b0190","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.gene.2017.07.068","article-title":"Association of clinical severity of cystic fibrosis with variants in the SLC gene family (SLC6A14, SLC26A9, SLC11A1 and SLC9A3)","volume":"629","author":"Pereira","year":"2017","journal-title":"Gene"},{"key":"10.1016\/j.gene.2023.147428_b0195","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/ppul.24005","article-title":"Interaction among variants in the SLC gene family (SLC6A14, SLC26A9, SLC11A1, and SLC9A3) and CFTR mutations with clinical markers of cystic fibrosis","volume":"53","author":"Pereira","year":"2018","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.gene.2023.147428_b0200","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222313064","article-title":"Synergy in cystic fibrosis therapies: targeting SLC26A9","volume":"22","author":"Pinto","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.gene.2023.147428_b0205","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2147\/JEP.S255377","article-title":"Pharmacological modulation of ion channels for the treatment of cystic fibrosis","volume":"13","author":"Pinto","year":"2021","journal-title":"J. Exp. Pharmacol."},{"key":"10.1016\/j.gene.2023.147428_b0210","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/j.jcf.2019.10.020","article-title":"Alternative chloride transport pathways as pharmacological targets for the treatment of cystic fibrosis","volume":"19","author":"Quesada","year":"2020","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.gene.2023.147428_b0215","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13073-021-00835-9","article-title":"CADD-Splice-improving genome-wide variant effect prediction using deep learning-derived splice scores","volume":"13","author":"Rentzsch","year":"2021","journal-title":"Genome Med."},{"key":"10.1016\/j.gene.2023.147428_b0220","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"10.1016\/j.gene.2023.147428_b0225","doi-asserted-by":"crossref","first-page":"41188","DOI":"10.1038\/srep41188","article-title":"Whole-exome sequencing of 228 patients with sporadic Parkinson's disease","volume":"7","author":"Sandor","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.gene.2023.147428_b0230","doi-asserted-by":"crossref","first-page":"18269","DOI":"10.1074\/jbc.RA119.010192","article-title":"The anion transporter SLC26A9 localizes to tight junctions and is degraded by the proteasome when co-expressed with F508del-CFTR","volume":"294","author":"Sato","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.gene.2023.147428_b0235","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3390\/genes12040562","article-title":"Cystic fibrosis lung disease modifiers and their relevance in the new era of precision medicine","volume":"12","author":"Sepahzad","year":"2021","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.gene.2023.147428_b0240","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1479-7364-8-11","article-title":"Ranking non-synonymous single nucleotide polymorphisms based on disease concepts","volume":"8","author":"Shihab","year":"2014","journal-title":"Hum. Genomics"},{"key":"10.1016\/j.gene.2023.147428_b0245","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/apm.12915","article-title":"Cystic fibrosis - an example of personalized and precision medicine","volume":"127","author":"Skov","year":"2019","journal-title":"APMIS"},{"key":"10.1016\/j.gene.2023.147428_b0250","doi-asserted-by":"crossref","first-page":"W446","DOI":"10.1093\/nar\/gkab266","article-title":"MutationTaster2021","volume":"49","author":"Steinhaus","year":"2021","journal-title":"Nucleic Acids Res."}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037811192300269X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037811192300269X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T22:23:05Z","timestamp":1736374985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037811192300269X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":50,"alternative-id":["S037811192300269X"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2023.147428","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of single nucleotide variants in SLC26A9 gene in patients with cystic fibrosis (p.Phe508del homozygous) and its association to Orkambi\u00ae (Lumacaftor and Ivacaftor) response in vitro","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2023.147428","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"147428"}}